MA26726A1 - Composition pharmaceutique de resorcinol, et procede pour sa preparation - Google Patents

Composition pharmaceutique de resorcinol, et procede pour sa preparation

Info

Publication number
MA26726A1
MA26726A1 MA25937A MA25937A MA26726A1 MA 26726 A1 MA26726 A1 MA 26726A1 MA 25937 A MA25937 A MA 25937A MA 25937 A MA25937 A MA 25937A MA 26726 A1 MA26726 A1 MA 26726A1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical composition
resorcinol
skin
relates
Prior art date
Application number
MA25937A
Other languages
English (en)
Inventor
William Collington Eric
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26726A1 publication Critical patent/MA26726A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03—Liquid compositions with two or more distinct layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION CONCERNE UNE COMPOSITION PHARMACEUTIQUE TOPIQUE COMPRENANT UN COMPOSÉ DE FORMULE I ELLE CONCERNE ÉGALEMENT UN PROCÉDÉ POUR SA PRÉPARATION. APPLICATION : UTILISATION DE CETTE COMPOSITION POUR L'ÉCLAIRCISSEMENT DE LA PEAU OU LA RÉDUCTION DE LA PIGMENTATION DE LA PEAU CHEZ UN PATIENT HUMAIN.
MA25937A 1999-03-22 2000-03-21 Composition pharmaceutique de resorcinol, et procede pour sa preparation MA26726A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12555399P 1999-03-22 1999-03-22

Publications (1)

Publication Number Publication Date
MA26726A1 true MA26726A1 (fr) 2004-12-20

Family

ID=22420269

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25937A MA26726A1 (fr) 1999-03-22 2000-03-21 Composition pharmaceutique de resorcinol, et procede pour sa preparation

Country Status (45)

Country Link
EP (1) EP1165031B1 (fr)
JP (1) JP2002539234A (fr)
KR (1) KR100468250B1 (fr)
CN (1) CN1213726C (fr)
AP (1) AP1413A (fr)
AR (1) AR018475A1 (fr)
AT (1) ATE297187T1 (fr)
AU (1) AU765209B2 (fr)
BG (1) BG65146B1 (fr)
BR (1) BR0009194A (fr)
CA (1) CA2366623C (fr)
CO (1) CO5160291A1 (fr)
CR (1) CR6452A (fr)
CZ (1) CZ298939B6 (fr)
DE (1) DE60020682T2 (fr)
DZ (1) DZ3022A1 (fr)
EA (1) EA003866B1 (fr)
EE (1) EE200100489A (fr)
ES (1) ES2241580T3 (fr)
GE (1) GEP20043231B (fr)
GT (1) GT200000030A (fr)
HK (1) HK1044478B (fr)
HN (1) HN2000000033A (fr)
HR (1) HRP20010696A2 (fr)
HU (1) HUP0200684A3 (fr)
ID (1) ID30272A (fr)
IL (1) IL144848A0 (fr)
IS (1) IS6052A (fr)
MA (1) MA26726A1 (fr)
MY (1) MY133193A (fr)
NO (1) NO20014586L (fr)
NZ (1) NZ513453A (fr)
OA (1) OA11840A (fr)
PA (1) PA8492001A1 (fr)
PE (1) PE20001567A1 (fr)
PL (1) PL350905A1 (fr)
PT (1) PT1165031E (fr)
SK (1) SK285434B6 (fr)
TN (1) TNSN00055A1 (fr)
TR (1) TR200102741T2 (fr)
TW (1) TWI224011B (fr)
UY (1) UY26072A1 (fr)
WO (1) WO2000056279A1 (fr)
YU (1) YU67101A (fr)
ZA (1) ZA200106681B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816843B1 (fr) * 2000-11-23 2006-10-27 Actichem Inhibiteurs de l'enzyme 5 alpha-reductase
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
DE10324566A1 (de) 2003-05-30 2004-12-16 Symrise Gmbh & Co. Kg Verwendung von Diphenylmethan-Derivaten als Tyrosinase-Inhibitoren
FR2894582B1 (fr) 2005-12-12 2008-02-22 Fabre Pierre Dermo Cosmetique Sirna anti myosine va et depigmentation de la peau
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939136B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP2018510905A (ja) * 2015-02-16 2018-04-19 エグザンシャル 皮膚障害の予防又は治療のための組成物
EP3322291B1 (fr) 2015-07-14 2023-04-12 Unilever IP Holdings B.V. Composition antimicrobienne
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.

Also Published As

Publication number Publication date
DE60020682T2 (de) 2006-04-06
KR20010114233A (ko) 2001-12-31
ZA200106681B (en) 2002-08-14
WO2000056279A1 (fr) 2000-09-28
NZ513453A (en) 2003-04-29
ATE297187T1 (de) 2005-06-15
EA003866B1 (ru) 2003-10-30
TWI224011B (en) 2004-11-21
AP1413A (en) 2005-03-18
GEP20043231B (en) 2004-05-25
IL144848A0 (en) 2002-06-30
IS6052A (is) 2001-08-17
TNSN00055A1 (fr) 2005-11-10
OA11840A (en) 2005-08-22
EE200100489A (et) 2002-12-16
CN1213726C (zh) 2005-08-10
BG65146B1 (bg) 2007-04-30
HN2000000033A (es) 2001-02-02
HUP0200684A2 (en) 2002-08-28
CR6452A (es) 2004-03-24
EP1165031A1 (fr) 2002-01-02
AU2823000A (en) 2000-10-09
HUP0200684A3 (en) 2009-11-30
DZ3022A1 (fr) 2004-03-27
CN1344152A (zh) 2002-04-10
KR100468250B1 (ko) 2005-01-27
CA2366623A1 (fr) 2000-09-28
HK1044478A1 (en) 2002-10-25
BG106016A (en) 2002-05-31
MY133193A (en) 2007-10-31
ES2241580T3 (es) 2005-11-01
PA8492001A1 (es) 2002-02-21
BR0009194A (pt) 2001-12-18
GT200000030A (es) 2001-09-08
TR200102741T2 (tr) 2002-01-21
EP1165031B1 (fr) 2005-06-08
CZ20013339A3 (cs) 2002-07-17
HK1044478B (zh) 2005-12-09
NO20014586D0 (no) 2001-09-21
JP2002539234A (ja) 2002-11-19
PL350905A1 (en) 2003-02-10
DE60020682D1 (de) 2005-07-14
AU765209B2 (en) 2003-09-11
SK285434B6 (sk) 2007-01-04
PE20001567A1 (es) 2001-01-13
NO20014586L (no) 2001-11-21
CZ298939B6 (cs) 2008-03-19
AP2001002273A0 (en) 2001-09-30
HRP20010696A2 (en) 2002-08-31
YU67101A (sh) 2004-12-31
CO5160291A1 (es) 2002-05-30
EA200100853A1 (ru) 2002-02-28
ID30272A (id) 2001-11-15
PT1165031E (pt) 2005-09-30
UY26072A1 (es) 2000-10-31
AR018475A1 (es) 2001-11-14
CA2366623C (fr) 2006-06-13
SK13222001A3 (sk) 2002-08-06

Similar Documents

Publication Publication Date Title
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
CA2238465A1 (fr) Composes triaromatiques, compositions les contenant et utilisations
TNSN98176A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
CA2224528A1 (fr) Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
MA27427A1 (fr) Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie
AU3804500A (en) 2-amino-6-anilino-purines and their use as medicaments
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
ATE237324T1 (de) Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen
ATE314067T1 (de) Cannabinol-11-säurederivate als entzündungshemmer und analgetika
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
CA2218766A1 (fr) Composes bicycliques-aromatiques
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
CA2264979A1 (fr) Composes bicycliques-aromatiques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
BR0214140A (pt) Derivados de piperidina e sua utilização como moduladores da atividade de receptor de quimiocina (especialmente ccr5)
MA26725A1 (fr) Derives de resorcinol, compositions pharmaceutiques les contenant et procede pour leur preparation
WO2001092218A3 (fr) Nouveaux analogues de polyamine a utiliser en tant qu'agents therapeutiques et diagnostiques
CA2147807A1 (fr) Composes bicycliques-aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
EA200000176A1 (ru) Применение физиологически приемлемых соединений, солей и комплексов ванадия
CA2171675A1 (fr) Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
AU2030497A (en) Propynyl or dienyl biaromatic compounds
TNSN00055A1 (fr) Composition pharmaceutique de resorcinol, et procede pour sa preparation
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.